Ignite Creation Date:
2024-05-06 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05132127
Status:
COMPLETED
Last Update Posted:
2023-10-03
First Post:
2021-11-11
Brief Title:
Sutimlimab BIVV009 for the Adult Participants With Cold Agglutinin Disease CAD Who Have Completed Phase 3 Studies CARDINAL or CADENZA in Japan
Sponsor:
Organization:
Sanofi